Arthritis & Rheumatology · 2014 · 71 citations · 40 references
Life SciencesCell BiologyImmunologyAutoimmunityImmunopathologyImmunoregulationAutoimmune DiseasesB Cell ActivationB Cell BiologyHumoral ImmunityImmune RegulationSystemic Lupus ErythematosusActivated B Cell ResponsesAutoimmune Disease SuppressionB Cell Receptor RecognitionRegulatory B Cell FunctionSuppressor Cell BiologySystemic Autoimmune Disease AssociationSystemic Lupus Erythematosus AssociationsT Helper Cells
OBJECTIVE: B cells with immunoregulatory properties (Breg cells) have been described in mice, but their role in the control of human immune responses is not well defined. We recently identified a human population of activated FSC(high) B cells that exhibited regulatory activity toward T helper cells. The aim of the present study was to test such induced Breg (iBreg) cells in patients with autoimmune disease. METHODS: Purified CD19+FSC(high) B cells derived from patients with systemic lupus erythematosus (SLE) or from healthy donors, which were activated via their B cell receptor, were cocultured with CD3-stimulated CD4+ T helper cells from SLE patients or healthy donors. (3) H-thymidine incorporation, flow cytometry, and enzyme-linked immunosorbent assay (ELISA) were used to analyze proliferation, cytokine secretion, and surface marker expression. RESULTS: Although under costimulatory conditions, FSC(high) SLE B cells supported the proliferation of healthy donor T cells to a similar extent as donor B cells, their regulatory function was significantly diminished in B cell suppressor assays. Similar effects were seen when SLE T cells were used, confirming that SLE T cells were equally susceptible to iBreg cell signals as healthy donor T cells and that SLE iBreg cell defects were independent of T cell origin. B cell viability and expression of surface markers (CD25, CD80, and B7-H1) or cytokines (interleukin-6 [IL-6], tumor necrosis factor α, and IL-10) were comparable in the two B cell populations. There was no correlation between the extent of iBreg cell-induced inhibition and disease activity. CD19+FSC(high) B cells from patients with another systemic autoimmune disease, granulomatosis with polyangiitis (Wegener's) (GPA), exhibited no regulatory defects, which suggests that the iBreg cell defects were SLE-specific and not a general consequence of autoimmunity or inflammation. CONCLUSION: Induced Breg cells from SLE patients, but not GPA patients, are less effective in the control of T helper cell proliferation, which supports the reported skewed B cell repertoire in SLE. The malfunctioning SLE iBreg cells might allow the overstimulation of immune responses and contribute to the initiation and/or perpetuation of disease.
40
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Derivation of the sledai. A disease activity index for lupus patients
Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz et al. · Arthritis & Rheumatism · 1992 · 4.6K citations
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Jason D. Fontenot, Jeffrey P. Rasmussen, Marc A. Gavin et al. · Nature Immunology · 2005 · 1.8K citations
B cells regulate autoimmunity by provision of IL-10
Simon Fillatreau, Claire H. Sweenie, Mandy J. McGeachy et al. · Nature Immunology · 2002 · 1.6K citations